Introduction {#section0005}
============

Viruses must target structural proteins and genetic material to a specific location in infected cells for efficient assembly of new particles. After assembly, the virus particles must exit the cell in order to gain access to other susceptible cells or to spread from the infected host. Viruses that assemble at the plasma membrane exit the cell by budding directly into the extracellular milieu. Alternatively, some viruses assemble by budding through intracellular membranes and must then be transported to the plasma membrane -- a process called virus egress ([@bib58]). The assembly of several important human pathogens -- hepatitis C virus ([@bib45]), rotavirus ([@bib42]), herpes simplex virus types 1 and 2 ([@bib48]), SARS coronavirus ([@bib37]) and various poxviruses ([@bib51], [@bib82]) -- occurs at intracellular membranes, but little is known about the trafficking pathways used to deliver the newly formed viral particles to the plasma membrane ([@bib37], [@bib39], [@bib45], [@bib51]).

Hantaviruses are members of the *Bunyaviridae* family that are further subdivided into Old World and New World groupings ([@bib75]). The Old World hantaviruses are primarily found in Asia and Europe and include Hantaan virus, the causative agent of hemorrhagic fever with renal syndrome (HFRS) ([@bib43], [@bib75]). New world hantaviruses, including Sin Nombre and Andes viruses, are found in North and South America, respectively, and are the causative agents of hantavirus pulmonary syndrome (HPS) ([@bib17], [@bib55], [@bib89]).

A hantavirus genome consists of three single-stranded, negative-sense RNA segments ([@bib29]) and the entire replication cycle takes place in the cytoplasm ([@bib29]) with little cytopathic effects on the infected cell ([@bib27], [@bib49], [@bib71]). Only four proteins are known to be expressed from the genome --- the RNA-dependent RNA polymerase (L), two glycoproteins (G~N~ and G~C~) produced by proteolytic cleavage of a precursor protein, and the nucleocapsid protein (N) ([@bib29]). The viral proteins and RNA localize to intracellular membranes, believed to be part of the Golgi apparatus, particles then bud into the luminal space and are transported to the plasma membrane via a vesicular trafficking pathway that has not been characterized to date ([@bib22], [@bib29], [@bib65], [@bib72], [@bib79]).

RabGTPases (Rabs) are a large family of small molecular weight proteins ([@bib84]) that are critical mediators of vesicle formation, trafficking, and fusion ([@bib81], [@bib99]). Rabs gain their specificity for various membranes through interactions with effector molecules ([@bib25], [@bib62]) and play key roles in many important vesicular transport pathways, including Golgi to plasma membrane transport ([@bib81], [@bib99]).

Rab8 and Rab11 have been shown to be critical in trafficking proteins from the Golgi to plasma membrane ([@bib2], [@bib11], [@bib44], [@bib100]). Rab8 and Rab11 are found at the *trans-*Golgi and the recycling endosome, a post-Golgi compartment that serves as a transport intermediate for some cargo *en route* from the TGN to the plasma membrane ([@bib3], [@bib11], [@bib44]). Disruption of either Rab8- or Rab11-specific pathways leads to inhibition of recycling endosome-dependent TGN to plasma membrane transport as well as plasma membrane recycling ([@bib2], [@bib3], [@bib7], [@bib11], [@bib44], [@bib53], [@bib74], [@bib100]). However, the recycling endosome, Rab8, and Rab11 are not required for trafficking of all proteins from the TGN to plasma membrane as plasma membrane delivery of the Influenza A virus hemagglutinin protein is unaffected by inhibition of Rab8 or Rab11 trafficking pathways ([@bib11], [@bib44], [@bib97]). This indicates that specific sorting events occur to direct cargo into multiple transport pathways (i.e. recycling endosome-dependent and independent) to facilitate delivery from the TGN to the plasma membrane.

Viruses often hijack existing cellular pathways in order to complete various stages of their life cycle. We investigated the vesicular trafficking pathways important for ANDV release from infected cells and describe a role for the recycling endosome, and specifically Rab8 and Rab11, during ANDV exit from non-polarized epithelial cells.

Results {#section0010}
=======

ANDV N forms cytoplasmic inclusions and localizes to intracellular vesicular membranes {#section0015}
--------------------------------------------------------------------------------------

Viruses in the family *Bunyaviridae* are thought to primarily assemble at membranes of the Golgi and *trans*-Golgi network (TGN) and these cellular compartments likely play a critical role in ANDV replication and assembly. We focused our studies on the nucleocapsid protein because it is the most abundant protein in the virion ([@bib35]) and localizes to the site of viral RNA replication and particle assembly ([@bib22], [@bib29], [@bib65]). While the ANDV glycoproteins have been shown to localize to the Golgi and TGN during infection and from cDNA expression ([@bib14]), little is known about the localization of ANDV N with this compartment. To determine the intracellular localization of ANDV N during infection, immunofluorescence confocal microscopy was performed on ANDV-infected Vero cells immunostained for ANDV N and various markers of the Golgi and TGN ([Fig. 1](#fig1){ref-type="fig"} ). ANDV N showed partial overlap with GM130, Golgin-97 and TGN46, however the extent of colocalization differed slightly. The greatest degree of colocalization was observed with GM130 ([Fig. 1](#fig1){ref-type="fig"}A), a protein associated with the *cis*-Golgi ([@bib61]). Less colocalization was observed with Golgin97 ([Fig. 1](#fig1){ref-type="fig"}B), a membrane-associated protein of the TGN ([@bib26], [@bib98]). ANDV N consistently showed more colocalization with membranes positive for TGN46 ([Fig. 1](#fig1){ref-type="fig"}C) than membranes positive for Golgin97. TGN46 is an integral membrane protein that recycles between the plasma membrane and TGN, but the recycling kinetics result in TGN enrichment ([@bib24], [@bib70]). While there was only partial overlap of ANDV N with the Golgi markers, the remaining ANDV N was consistently in close proximity to all of the Golgi markers, suggesting a close spatial relationship between nucleocapsid and the Golgi. This data indicates that while a portion of ANDV N does localize with Golgi and TGN membranes, the majority of the protein appears to be proximal but not associated with these membrane compartments.Fig. 1ANDV N partially localizes to the Golgi and *trans-*Golgi during infection. Vero cells were infected with ANDV and fixed for immunofluorescence at 2 dpi. Cells were immunostained for ANDV N (green, Alexa Fluor 488) and the following Golgi and *trans*-Golgi markers (red, Alexa Fluor 555) (A) GM130, (B) Golgin97, and (C) TGN46. Cells were visualized using confocal microscopy. Nuclei (blue) were counterstained with TO-PRO-3 and are shown in the merged panels only. All images are confocal single planes acquired at a 63× optical magnification and 3× digital zoom.

To gain additional insights on the location of ANDV N during infection, immuno-electron microscopy was performed on ANDV-infected cells ([Fig. 2](#fig2){ref-type="fig"} ). ANDV N was localized throughout the cytoplasm but concentrated in the perinuclear region ([Fig. 2](#fig2){ref-type="fig"}). ANDV N was primarily localized to large, granulofilamentous structures surrounded by large numbers of mitochondria ([Figs. 2](#fig2){ref-type="fig"}A and B). These structures were not membrane-bound, but were proximal to intracellular membranes resembling Golgi cisternae ([Fig. 2](#fig2){ref-type="fig"}C). Smaller accumulations of ANDV N, not in filamentous structures, also localized to the membranes of small vesicles in close proximity to the Golgi ([Figs. 2](#fig2){ref-type="fig"}C and D). Additionally, the structure of the Golgi was altered, with extensive small vesicles surrounding the cisternae ([Figs. 2](#fig2){ref-type="fig"}C and D). There was no ANDV N found present at the plasma membrane or enclosed within membrane structures (∼ 75 cells observed, data not shown), and even with large amounts of ANDV N present in the infected cells, no obvious structures resembling viral particles were detected. This data suggests that there are two cellular pools of ANDV N, one that is present in large, granulofilamentous structures not significantly associated with membranes and one that is membrane-associated.Fig. 2Ultrastructural analysis of ANDV N during infection by immunoelectron microscopy. At 2 d (A and B) and 4 d (C and D) post infection, ANDV-infected Vero cells were and immunolabeled using ANDV N-specific rat immunesera followed by secondary antibody conjugated to 12 nm colloidal gold particles. Granulofilamentous structures are indicated with an asterisk (⁎), while vesicle-associated ANDV N is noted by arrowheads. Cellular structures are denoted as follows: mitochondria (M), Golgi (G), and nucleus (N). Scale bars represent 100 or 200 nm as indicated. The image in panel (B) is a cropped and digital zoom of a region in panel (A), and was performed using Adobe Photoshop.

ANDV N colocalizes with Rabs of the recycling endosome {#section0020}
------------------------------------------------------

In order to determine the role of various cellular trafficking pathways in ANDV replication we focused our remaining studies on the portion of ANDV N localized to intracellular vesicular membranes. ANDV N is predicted to be a peripheral membrane protein that exists in a dynamic equilibrium between membrane bound and cytosolic pools ([@bib29], [@bib35], [@bib65]). To identify specific vesicular populations during infection, ANDV-infected cells were transfected with cDNAs encoding eGFP-fusion proteins associated with various host cell trafficking pathways and analyzed by confocal microscopy for colocalization of eGFP with ANDV N protein. Using 3-D reconstructions of serial Z-stack images acquired by confocal microscopy (data not shown) we were able to focus on the portion of membrane-associated ANDV N in infected cells expressing cDNAs of proteins associated with various vesicular transport pathways. ANDV-infected cells expressing eGFP-Rab 8 ([Fig. 3](#fig3){ref-type="fig"}A) or eGFP-Rab11 ([Fig. 3](#fig3){ref-type="fig"}B) show a high degree of colocalization between ANDV N and either Rab protein. We measured the degree of colocalization using parameters within the Volocity software that allowed us to focus on the viral antigen that was associated with the vesicular trafficking proteins (described in the [Materials and methods](#sec1){ref-type="sec"}). The percent of eGFP colocalizing with ANDV N was determined by dividing the total colocalization volume by the volume of eGFP, and expressed as percent colocalization ([Fig. 3](#fig3){ref-type="fig"}C). Using this calculation, Rab8 and Rab11 had the highest level of colocalization with ANDV N, with 30.1% and 29.2% of the eGFP-Rab proteins colocalizing with ANDV N, respectively. Rabs associated with early endosomes (eGFP-Rab5a), late endosomes (eGFP-Rab7), and late endosomes/lysosomes (Rab9) showed colocalization that was clearly less than that observed with eGFP-Rab8 and eGFP-Rab11. Proteins associated with the multivesicular bodies (CD63-eGFP and eGFP-Vps4A) showed limited colocalization ([Fig. 3](#fig3){ref-type="fig"}C). Taken together, these results suggest that the recycling endosome-associated Rabs 8 and 11 colocalize with ANDV N and therefore may play a role in ANDV replication.Fig. 3ANDV N localizes to the recycling endosome and has little colocalization with proteins of other vesicular trafficking pathways. (A and B) Vero cells were infected with ANDV, then transfected at 3 dpi with cDNAs expressing (A) eGFP-Rab8 or (B) eGFP-Rab11 fusion proteins (green). Cells were fixed 18 hpt, immunostained for ANDV N (red, AlexaFluor 594), counterstained for the nucleus with TO-PRO-3 (blue), and visualized using confocal microscopy. 3-D reconstructions were created from confocal z-stacks using the Improvision Volocity imaging software. The regions of colocalization between eGFP and ANDV N can be seen in yellow. (C) 3-D regions of colocalization between ANDV N and eGFP-fusion proteins were measured as described in the Materials and methods. The volume of colocalization was normalized to the volume of eGFP and expressed as percent colocalization. The trafficking molecules were grouped into the following trafficking pathways: endosome (blue bars), recycling endosome (red bars), late endosome/lysosome (yellow bars), and multvesicular body (MVB, green bars). Data presented is the mean of four independent experiments and at least 5 cells per cDNA transfection in each experiment.

Many viral proteins show similar subcellular localization during infection and when expressed independently from cDNA. In order to determine if viral proteins colocalized with Rab8 and Rab11 when expressed from cDNA, Vero cells were transfected with cDNAs expressing either ANDV N ([Supplemental Figs. 1A and D](#app1){ref-type="sec"}) or the ANDV glycoprotein ORF (M), which expresses both G~N~ and G~C~ ([Supplemental Figs. 1B and E](#app1){ref-type="sec"}), with either eGFP-Rab8 ([Supplemental Figs. 1A and B](#app1){ref-type="sec"}) or eGFP-Rab11 ([Supplemental Figs. 1D and E](#app1){ref-type="sec"}). Cells were then immunostained for either ANDV N or ANDV glycoproteins and analyzed by confocal microscopy. ANDV N and the ANDV glycoproteins colocalized with eGFP-Rab8 and eGFP-Rab11, suggesting that both proteins can localize to cellular membranes enriched in Rab8 and Rab11 independently of virus infection. The vesicular stomatitis virus G (VSV G) protein has been shown to traffic from the Golgi to the plasma membrane via Rab8- ([@bib2], [@bib3], [@bib44]) and Rab11-dependent pathways ([@bib11]). As expected, VSV G colocalized extensively with both eGFP-Rab8 and eGFP-Rab11 ([Supplemental Figs. 1C and F](#app1){ref-type="sec"}).

ANDV N colocalizes with endogenous Rab8 and Rab11 during infection {#section0025}
------------------------------------------------------------------

The data in [Fig. 3](#fig3){ref-type="fig"} indicated that ANDV N could localize to cellular membranes containing cDNA expressed eGFP-Rab8 or eGFP-Rab11. To determine if the ANDV N colocalized with the endogenous forms of Rab8 and Rab11, mock- or ANDV-infected Vero cells were immunostained at 3 dpi for ANDV N and either endogenous Rab8 ([Fig. 4](#fig4){ref-type="fig"}A) or Rab11 ([Fig. 4](#fig4){ref-type="fig"}B). The signal intensity for immunostaining of endogenous Rabs was lower when compared to the cDNA-expressed eGFP proteins --- most likely a combination of higher expression levels of the plasmid expressed fusion proteins and the intense fluorescence signal of eGFP. While endogenous Rab8 was readily detectable, endogenous Rab11 consistently showed low fluorescent intensity (compare green fluorescence images in [Fig. 4](#fig4){ref-type="fig"}). Despite the low level of signal intensity there were notable regions of colocalization between ANDV N and both Rab8 ([Fig. 4](#fig4){ref-type="fig"}a) and Rab11 ([Fig. 4](#fig4){ref-type="fig"}b), suggesting that a portion of ANDV N expressed during infection was present at membranes containing Rab8 and Rab11 and providing further support for a role for Rab8 and Rab11 during ANDV infection. ANDV N protein also colocalized with fluorescently labeled transferrin (data not shown), further supporting a role for the recycling endosome in ANDV infection.Fig. 4ANDV N colocalizes with endogenous Rab8 and Rab11 during infection. Mock- or ANDV-infected Vero cells were fixed at 3 dpi and immunostained for ANDV N (red, AlexaFluor 594) and either (A) Rab8 (green, AlexaFluor 488) or (B) Rab11 (green, AlexaFluor 488). Nuclei were counterstained with TO-PRO-3 (blue) and are shown in the merged images only. All images were acquired at 63× magnification. Digital zoom (2×) images of the boxed area in the merged panels for (a) Rab8 and (b) Rab11 are also shown.

Dominant negative and constitutively active forms of Rab11 have altered levels of colocalization with ANDV N during infection {#section0030}
-----------------------------------------------------------------------------------------------------------------------------

Amino acid substitutions at highly conserved residues within RabGTPases create proteins that are no longer capable of GDP--GTP cycling. A serine to asparagine mutation at position 25 (S25N) in Rab11 results in constitutive binding of GDP and locks the protein in a dominant negative form. In contrast, a glutamine to lysine mutation at position 70 (Q70L) prevents GTP hydrolysis, resulting in a constitutively active protein. The analogous mutations in Rab8 are T22N and Q70L. These mutant proteins often display altered subcellular localization due to augmented protein--protein interactions ([@bib11], [@bib28], [@bib68], [@bib73]). To determine if expression of mutated eGFP-Rab8 and -Rab11 proteins during ANDV infection altered the colocalization of these proteins with ANDV N, infected Vero cells were transfected with cDNAs expressing eGFP-fusions of either wild-type, dominant negative (GDP-bound), or constitutively active (GTP-bound) mutants of eGFP-Rab8 and 11 ([Fig. 5](#fig5){ref-type="fig"} ). There were notable differences in the subcellular distribution of the eGFP-Rab8 proteins. The GDP-bound form (Rab8T22N) had a tighter perinuclear localization and fewer effects on cell morphology ([Fig. 5](#fig5){ref-type="fig"}B), while the GTP-bound protein (Rab8Q67L, [Fig. 5](#fig5){ref-type="fig"}C) had an expression pattern similar to wild-type eGFP-Rab8 ([Fig. 5](#fig5){ref-type="fig"}A) ([@bib28], [@bib73]). Interestingly, both forms of eGFP-Rab8 displayed similar levels of colocalization with ANDV N compared to wild-type Rab8 ([Figs. 5](#fig5){ref-type="fig"}A--C, quantitated data in [Fig. 5](#fig5){ref-type="fig"}D). In contrast, eGFP-Rab11S25N showed increased levels of colocalization with ANDV N while the constitutively active eGFP-Rab11Q70L showed an approximately 50% decrease in colocalization when compared to eGFP-Rab11 ([Figs. 5](#fig5){ref-type="fig"}E--G, quantitated data in [Fig. 5](#fig5){ref-type="fig"}H).Fig. 5Dominant negative and constitutively active forms of Rab11 have altered levels of colocalization with ANDV N during infection. ANDV-infected Vero cells were transfected with cDNAs expressing (A) wild-type, (B) T22N mutant, GDP-bound dominant negative, and (C) Q67L mutant, GTP-bound constitutively active, forms of eGFP-Rab8 (green); and (E) wild-type, (F) S25N mutant, GDP-bound dominant negative, and (G) Q70L mutant, GTP-bound constitutively active, forms of eGFP-Rab11 (green). At 18 hpt, cells were fixed and immunostained for ANDV N (red, AlexaFluor 555). Nuclei were counterstained with TO-PRO-3 (blue) and are shown in the merged images only. All images are flattened reconstructions of confocal z-stacks acquired at 63× optical magnification and 2× digital zoom. Levels of colocalization between ANDV N and (D) eGFP-Rab8 and (H) eGFP-Rab11 proteins were quantitated using the Volocity imaging software. Data presented is the mean of three independent experiments and at least 5 cells per cDNA transfection in each experiment.

Rab11 has been reported to function in trafficking between the *trans-*Golgi and recycling endosome, therefore, we determined the localization of the eGFP-Rab11 proteins with respect to the *trans-*Golgi marker, TGN46 ([Fig. 6](#fig6){ref-type="fig"} ). Wild-type eGFP-Rab11 showed partial localization with TGN46 ([Fig. 6](#fig6){ref-type="fig"}A), while the Q70L mutant showed limited overlap ([Fig. 6](#fig6){ref-type="fig"}C). In contrast, the membrane-associated portion of Rab11S25N showed almost complete localization with TGN46 ([Fig. 6](#fig6){ref-type="fig"}B). These data are consistent with previous reports that the dominant negative Rab11 localizes to the TGN, while the constitutive active form localizes at the recycling endosome ([@bib11], [@bib53]).Fig. 6Dominant negative and constitutively active forms of Rab11 localize to distinct membrane compartments. Vero cells were transfected with cDNAs expressing eGFP-Rab11 (A) wild-type, (B) S25N, or (C) Q70L proteins (green). At 18 hpt, cells were fixed and immunostained for the *trans-*Golgi marker, TGN46 (red, AlexaFluor 594). Nuclei were counterstained with TO-PRO-3 (blue) and are shown in the merged images only. All images are flattened reconstructions of confocal z-stacks acquired at 63× optical magnification and 2× digital zoom.

siRNA-mediated downregulation of Rab8 and Rab11 block ANDV secretion {#section0035}
--------------------------------------------------------------------

To determine if Rabs 8 and 11 played a functional role in ANDV release from infected cells, RNA interference (RNAi) ([@bib16]) was utilized to downregulate Rab8 and Rab11 protein expression during infection. Many cell surface receptors, including the hantavirus receptor β3 integrin, are recycled through the recycling endosome ([@bib34]), therefore downregulation of molecules within this pathway could alter surface expression of the viral receptor, thus affecting virus entry. To avoid altering early events in the virus life cycle, we took advantage of the fact that ANDV infection of Vero cells leads to prolonged, low level virus secretion with little obvious cytopathic effects ([@bib27], [@bib49], [@bib71]). Seventy-two hours following ANDV infection, Vero cells were transfected with siRNAs specific for the a or b isoforms of Rabs 8 and 11, along with siRNA controls. At this time, over 90% of the cells are expressing viral antigen (data not shown). Since most cells express two isoforms (a and b) of Rab8 and Rab11 ([@bib40], [@bib41]), we utilized pooled siRNAs specific for either the a isoform or both the a and b isoforms. Four siRNAs per target transcript were used. At 48 hpt, there was a significant decrease in the Rab8 protein expression levels ([Fig. 7](#fig7){ref-type="fig"}A) after transfection with siRNAs targeting Rab8a (52.7% decrease) or both Rab8a and 8b isoforms (51.6% decrease). Transfection of siRNAs specific for Rab11a or Rab11a and 11b isoforms, as well as transfection reagent alone (siQst) resulted in no changes in Rab8 expression levels ([Fig. 7](#fig7){ref-type="fig"}A). There was also a significant decrease in the Rab11 protein expression levels ([Fig. 7](#fig7){ref-type="fig"}A) after transfection with siRNAs targeting Rab11a (78.1% decrease) or both Rab11a and 11b isoforms (61.9% decrease), again with no off-target effects from siRNAs targeting Rab8 isoforms. Unfortunately, the antibodies used cannot distinguish between the two isoforms, so we could not determine the specific downregulation of the b isoforms. Downregulation of all four targets (Rab8a and 8b, Rab11a and 11b) resulted in significant decreases in both Rab8 (48.8% decrease) and Rab11 (61.3% decrease) proteins ([Fig. 7](#fig7){ref-type="fig"}A). The level of β-actin expression was not altered after any siRNA transfection ([Fig. 7](#fig7){ref-type="fig"}A). The treatment of cells with structured, double stranded RNAs can lead to host cell antiviral responses that can inhibit viral replication ([@bib86]). Intracellular ANDV N levels remained constant after siRNA transfection ([Fig. 7](#fig7){ref-type="fig"}B), indicating there were no adverse effects of siRNA transfection on viral protein production.Fig. 7siRNA downregulation of Rabs of the recycling endosome block ANDV egress. Vero cells were infected with ANDV and at 3 dpi were transfected with the following siRNAs: siGlo (100 nM, RISC-binding deficient siRNA), murine PKR (100 nM, unrelated siRNA), Rab8a (100 nM), Rab8a and b (50 nM each), Rab11a (100 nM), Rab11a and b (50 nM each), and quadruple knockdown Rab8a and b, and Rab11a and b (50 nM each). (A) The cells were lysed at 48 hpt and the amount of Rab8, Rab11, and β-actin were determined by western blot analysis. (B) Intracellular ANDV N levels at 48 hpt were determined by Western blot analysis. Protein levels were normalized to GAPDH. (C) Supernatants were harvested at the time of transfection (0 h) and 48 hpt. Virus titer was determined by immune TCID~50~ analysis. The fold decrease in virus titer between 0 h and 48 h was determined. Data presented is the mean of four independent experiments with duplicate wells analyzed for each condition.

In order to assess if siRNA treatments altered the secretion of infectious virus particles, infected-cell supernatants were harvested immediately before and 48 h after siRNA transfection. Infectious virus production was quantified by an immune TCID~50~ assay and expressed as a fold decrease in virus production ([Fig. 7](#fig7){ref-type="fig"}C). Downregulation of Rab11a or Rab11a and 11b resulted in a nearly 10 fold decrease in virus secretion, indicating Rab11 isoforms were functionally important for ANDV release from infected cells. Transfection with control siRNAs (siQst, transfection reagent alone; siGlo, RISC-binding deficient siRNA; and murine PKR siRNA, a protein not associated with vesicular transport) did not alter the amount of infectious virus production when compared to mock-transfected cells, indicating there were no non-specific effects of siRNA transfection on ANDV virus production. Interestingly, siRNAs specific for Rab8a did not alter ANDV virus secretion ([Fig. 7](#fig7){ref-type="fig"}C) even though Rab8 levels were decreased significantly ([Fig. 7](#fig7){ref-type="fig"}A). However, downregulation of both Rab8a and 8b led to a 10-fold decrease in virus secretion. Decreasing all four Rab isoforms did not enhance the decrease virus secretion compared to downregulating Rab8a/b, Rab11a, or Rab11a/b. The data in [Fig. 7](#fig7){ref-type="fig"} demonstrates that Rabs associated with the recycling endosome play a functional role in ANDV secretion from epithelial cells, and specifically indicates Rab11a as a major host cell factor involved in this process.

Discussion {#section0040}
==========

Many viruses in the family *Bunyaviridae* assemble at Golgi membranes and new particles are transported to the plasma membrane via vesicular transport ([@bib54], [@bib72]). The vesicular trafficking mechanism utilized during hantavirus egress is poorly understood but the data presented in this study suggests trafficking through the recycling endosome may be a key step in this process for ANDV.

The nucleocapsid proteins of viruses within *Bunyaviridae* have been localized to multiple intracellular compartments. The nucleocapsids of Uukuniemi virus (genus *Phlebovirus*) and Black Creek Canal virus (BCCV, genus *Hantavirus*) have both been shown to localize to Golgi membranes ([@bib32], [@bib38], [@bib65]). In contrast, Hantaan virus (genus *Hantavirus*) and LaCrosse virus (genus *Orthobunyavirus*) nucleocapsids have been shown to localize to membranes of the endoplasmic reticulum (ER) and ER-Golgi intermediate compartment (ERGIC) ([@bib63], [@bib85]). Even though ANDV N had partial colocalization with Golgi and *trans*-Golgi markers by immunofluorescence confocal microscopy, a significant portion did not overlap with these markers. Electron microscopy studies further indicated two populations of nucleocapsid. The majority of ANDV N was localized to large cytoplasmic structures not obviously associated with membranes, which have been previously described as inclusion bodies in studies of other hantaviruses ([@bib22], [@bib30], [@bib66]). These structures may be caused by accumulation of large amounts of N protein in infected cells or may be the site of RNA replication as described for the orthobunyavirus, Bunyamwera ([@bib96]). Further studies will be required to determine the composition of these structures. A smaller portion of ANDV N was membrane-associated at vesicles proximal to the Golgi, which has been described for Uukuniemi virus N ([@bib32]). These vesicles could be part of the Golgi, *trans*-Golgi network, or post-Golgi secretory pathway. In order to identify these vesicles, we focused on proteins involved in host cell vesicular trafficking pathways. From these studies, the data suggests an involvement of the recycling endosome pathway and RabGTPases, Rab8 and Rab11, in ANDV release from infected cells.

Plasma membrane assembly has been noted for Sin Nombre virus (SNV) and BCCV, two New World hantaviruses ([@bib22], [@bib66]), however the lack of plasma membrane localization of ANDV N in the electron microscopy studies strongly suggests limited plasma membrane assembly. However, we could not confirm the site of ANDV assembly because no obvious structures resembling viral particles were observed by electron microscopy at high frequency. This is, perhaps, not surprising given the low numbers of ANDV particles released per cell. It may also be possible that the anti-nucleocapsid sera may not recognize ribonucleocapsids (RNPs) present in budding particles and fully assembled virions. However, based on the localization of ANDV proteins, it is likely that ANDV assembles at membranes of the Golgi or *trans*-Golgi, similar to that observed for Hantaan virus and other viruses in *Bunyaviridae* ([@bib10], [@bib30], [@bib38], [@bib72], [@bib88]).

Our proposed model of ANDV assembly and egress starts with ANDV protein concentrated at the site of assembly to form new particles by budding into the host cell membrane, which is enriched in Rab8 and Rab11 thereby, facilitating the access of newly formed particles to the correct egress trafficking pathway. Egress could then occur via a Rab8- and/or Rab11-mediated mechanism which traffics virus-containing vesicles to the recycling endosome. The virus particles could then be sorted into vesicles destined for the apical or basolateral plasma membrane. It is important to note that our studies utilized non-polarized Vero cells. Intracellular trafficking in polarized versus non-polarized cells may utilize slightly different pathways so an analysis of ANDV trafficking in other relevant cell types (e.g. polarized epithelial cells, macrophages, endothelial cells) is warranted.

The recycling endosome regulates plasma membrane recycling of many cell surface receptors, such as transferrin ([@bib3], [@bib68], [@bib74], [@bib78]), low-density lipoprotein (LDLR) ([@bib3]), and polyimmunoglobulin (pIg) receptors ([@bib4], [@bib69], [@bib78]). In addition to receptor recycling, the transport of select cargo from the Golgi to the plasma membrane is also regulated by this compartment ([@bib2], [@bib3], [@bib11], [@bib28], [@bib68]). Our model proposes a similar role for the recycling endosome in the transport of ANDV particles to the plasma membrane. Both the viral nucleocapsid and glycoproteins colocalized with eGFP-Rab8 and eGFP-Rab11 when expressed from cDNA. However, the localization of the nucleocapsid protein varied from cell to cell with some cells showing high levels of colocalization and others showing minimal colocalization. This variation seemed to be related to high nucleocapsid expression levels in some cDNA transfected cells, therefore we focused our intracellular localization studies on cells that had levels of viral protein similar to that observed in ANDV-infected cells.

The expression of constitutively active and dominant negative Rab11 proteins resulted in altered colocalization of the eGFP-fusion proteins with ANDV N during infection. The dominant negative Rab11S25N protein showed an enhanced colocalization with ANDV N, localizing closely at a perinuclear location, and is similar to observations in which Rab11S25N retained VSV G intracellularly at a perinuclear site, resulting in decreased G surface expression ([@bib11]). In stark contrast to Rab11S25N, the constitutively active Rab11Q70L showed a dramatic decrease in colocalization with ANDV N. It was further determined that the two mutant Rab11 proteins localize to distinct membrane compartments. Rab11S25N localized to the *trans-*Golgi, while Rab11Q70L showed limited localization with the *trans-*Golgi marker. Consistent with Rab11 function and our model of ANDV assembly and egress, the GDP-bound mutant localizes at the donor membrane (the *trans*-Golgi) ([@bib11], [@bib53]) and may retain or enhance ANDV N localization to that membrane compartment. In contrast the GTP-bound mutant localizes to the acceptor membrane (the recycling endosome) and by sequestering transport machinery at the recycling endosome may reduce trafficking of important host cell proteins involved in ANDV replication or trafficking of the viral proteins or particles themselves.

By utilizing RNAi, we determined that both Rab8 and Rab11 play a functional role in ANDV release from infected cells. Downregulation of Rab8a showed minimal effects on virus secretion and was similar to control transfections, however in cells transfected with siRNAs targeting Rab11a, a 10--15 fold decrease in virus secretion was observed. Downregulation both Rab11 isoforms did not enhance the effect on ANDV release seen with Rab11a downregulation alone, suggesting that Rab11a plays the predominant role in ANDV infection. In contrast, downregulating Rab8a had little effect on ANDV secretion but reducing the expression of both isoforms led to a 10-fold decrease in virus release. This result indicates that there is either redundancy in the Rab8 pathway, or Rab8b is playing a more important role in ANDV replication. It is unlikely that the effects of siRNA downregulation of Rab8 and Rab11 on virus secretion are caused by a nonspecific block in all post-Golgi secretion, since numerous studies indicate that Rab8- and Rab11-independent pathways of Golgi to plasma membrane transport exist ([@bib11], [@bib13], [@bib44], [@bib97]). Consistent with our model, the siRNA studies indicate an important role for Rab8 and Rab11 in ANDV replication. Given the low level of ANDV particle formation ([Fig. 2](#fig2){ref-type="fig"}), we were unable to identify the precise step at which ANDV particle egress was blocked after treatment of infected cells with Rab8 and Rab11 specific siRNAs. The siRNA sequences used were designed to recognize human forms of Rab 8 and 11 and may not be optimal for recognizing the corresponding proteins from African green monkeys. However, we utilized four siRNAs per construct and did in fact see downregulation of some Rab isoforms, indicating that siRNA downregulation of Rab transcripts was in fact occurring. A more extensive downregulation of Rab 8 and 11 protein levels may be needed to find the relatively low numbers of virus particles that are in the intracellular trafficking pathway during any particular time after ANDV infection.

Rab11a has been shown to play a role in the replication of respiratory syncytial virus (RSV) ([@bib7]), HIV-1 ([@bib52], [@bib92]), and another retrovirus, Mason--Pfizer monkey virus (M-PMV) ([@bib77]). In these examples, trafficking of viral proteins through the recycling endosome is required for the proteins to reach the site of particle formation at the plasma membrane, thus the recycling endosome is functioning prior to virus assembly. Although the experiments we performed have not formally ruled out a role for Rab8 and Rab11 in ANDV assembly or budding, Rab8- and Rab11-coated vesicles bud away from the membrane compartment into the cytoplasm and therefore have a different topology from that required to promote virus assembly into the Golgi lumen. Alternatively, disruption of Rab8 and Rab11 pathways could disrupt the localization of a host protein critical for virus assembly, and further studies will need to be performed to determine this possibility. Since ANDV assembly is hypothesized to occur at the Golgi, Rab8 and Rab11 are presumably altering trafficking steps that occur after virus assembly. This leads us to propose a model in which Rab8 and Rab11 are playing roles in steps of egress, downstream of virus assembly. To our knowledge, a role for the recycling endosome in post-assembly trafficking of viruses to the plasma membrane has not been described to date.

Hantaviruses may be utilizing the recycling endosome, and its function in polarized trafficking, to direct particles from the host cell in a directional fashion. Infection of polarized epithelial cells with viruses in the family *Bunyaviridae*, including ANDV, leads to the polarized release of virus particles. This release can be strictly apical, strictly basolateral, or a combination of both ([@bib10], [@bib12], [@bib21], [@bib66], [@bib71]) Since Rab8 and Rab11 play roles in polarized trafficking ([@bib2], [@bib3], [@bib7]), it is possible that ANDV utilizes these pathways to egress in a polarized fashion from cells. By utilizing the recycling endosome during egress, hantaviruses could be sorted in both the apical and basolateral direction and ensure appropriate viral spread and tissue tropism within the host.

Materials and methods {#sec1}
=====================

Reagents and antibodies {#section0045}
-----------------------

Anti-ANDV human convalescent sera (1:150 immunofluorescence) was kindly provided by Stephen St. Jeor (University of Nevada, Reno, NV). Rabbit anti-ANDV N sera (1:500 immunofluorescence) was kindly provided by Colleen Jonsson (Southern Research Institute, Birmingham, AL). A rat anti-ANDV N sera was raised by immunizing rats with purified, bacterially expressed glutathione-S-transferase (GST)-ANDV N fusion protein (1:1500 immunofluorescence, 1:5000 western blotting and immune TCID~50~, cryoelectron microscopy 1:2000). Other primary antibodies were used as follows: mouse anti-GM130 (1:100 immunofluorescence, BDBiosciences, San Jose, CA); mouse anti-Golgin97 (1:50 immunofluorescence, Molecular Probes/Invitrogen); sheep anti-TGN46 (1:250 immunofluorescence, Serotec, Oxford, UK); mouse anti-Rab8 and mouse anti-Rab11 (1:100 immunofluorescence; 1:1000 western blotting; BDBiosciences, San Jose, CA); rabbit anti-vesicular stomatitis virus glycoprotein (VSV G) (1:100 immunofluorescence, Bethyl Laboratories, Montgomery, TX); rabbit anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (1:1000 western blotting; Cell Signaling, Danvers, MA), and mouse anti-β-actin (1:15,000 western blotting, AbCam, Cambridge, MA). Secondary antibodies were used as follows: goat anti-rat Alexa Fluor 594, goat anti-rat Alexa Fluor 555, goat anti-mouse Alexa Fluor 488, goat anti-mouse Alexa Fluor 594, goat anti-human Alexa Fluor 633, and goat anti-rabbit Alexa Fluor 594, donkey anti-sheep Alexa Fluor 594 (1:500 immunofluorescence, Molecular Probes/Invitrogen, Carlsbad, CA); goat anti-rat horseradish peroxidase (HRP) (1:7500 western blot, 1:5000 immune TCID~50~), goat anti-mouse HRP and goat anti-rabbit HRP (1:7500 western blot, Jackson Immunoresearch, Westgrove, PA).

ANDV infection {#section0050}
--------------

Vero E6 cells (African green monkey kidney epithelial cells, American Type Culture Collection) were cultured as previously described and used under conditions where the cells were subconfluent and therefore not polarized ([@bib71]). Cells were infected with Andes virus, strain 9717869 (ANDV, courtesy of Stuart Nichol, Centers for Disease Control, Atlanta, GA) as previously described ([@bib71]). Infected cell supernatants were collected at the indicated times post infection or transfection and stored at − 70 °C until further analysis. All infections were performed using institution-approved biosafety level 3 (BSL3) containment procedures.

Immuno-electron microscopy {#section0055}
--------------------------

For ultrastructural analysis, ANDV-infected Vero cells were fixed at the indicated days post infection in 4% paraformaldehyde, 0.1% glutaraldehyde in (Polysciences, Warrington, PA) in 100 mM PIPES, pH 7.2 with 0.5 mM MgCl~2~ for 1 h at 4 °C. Samples were embedded in 10% gelatin and infiltrated with 2.3 M sucrose/20% polyvinyl pyrrolidone in PIPES/MgCl~2~ overnight at 4 °C. Samples were frozen in liquid nitrogen and 70 nm sections were cut using a Leica Ultracut UCT cryo-ultramicrotome (Leica Microsystems, Bannockburn, IL). Sections were blocked with 5% fetal bovine serum and 5% goat serum (blocking buffer) for 30 min and then incubated with primary antibody for 1 h at room temperature. Sections were washed for 30 min in blocking buffer and probed with 12 nm colloidal gold-conjugated goat anti-rat secondary antibody (Jackson ImmunoResearch Laboratories, West Grove, PA) for 1 h at room temperature. Sections were washed in PIPES buffer, followed by an extensive water rinse and stained with 1% uranyl acetate and 1.6% methyl cellulose (Ted Pella, Redding, CA). Samples were visualized with a JEOL 1200EX transmission electron microscope (JEOL USA, Peabody, MA) ([@bib6]).

Immune TCID~50~ assay {#section0060}
---------------------

Serial 5-fold dilutions of infected cell supernatants were made in Dulbecco\'s modified Eagles medium (DMEM) containing 2% fetal bovine sera (FBS, Atlanta Biologicals, Atlanta, GA). Confluent monolayers of Vero cells in 96-well dishes were infected with 100 μl/well in sextuplicate. The infected cells were incubated at 37 °C, 5% CO~2~ for 7 days at which time cells were washed 1× with PBS and fixed with cold 95% ethanol/5% acetic acid solution. For immunostaining, cells were rehydrated with phosphate buffered saline (PBS) and incubated in 3% bovine serum albumin (BSA, Calbiochem, San Diego, CA) in PBS (blocking buffer). Cells were incubated with rat anti-ANDV N antibody diluted in blocking buffer for 2 h at room temperature. Cells were washed with PBS and incubated with secondary antibody goat anti-rat HRP for 2 h at room temperature. Cells were washed in PBS and nucleocapsid positive wells were visualized by addition of soluble HRP substrate (DakoCytomation, Carpenteria, CA). Titers were calculated using the Reed--Muench formula ([@bib67]).

Plasmids {#section0065}
--------

The ANDV N open reading frame was amplified from ANDV vRNA and cloned into the pCAGGS ([@bib57]) and pCDNA3.1(+) (Invitrogen, Carlsbad, CA) mammalian expression vectors. Briefly, total cellular RNA was isolated from ANDV-infected Vero cells using the Qiagen cellular RNA mini prep kit according to the manufacturer\'s protocol (Qiagen, Valencia, CA). Using ANDV N ORF specific primers (Genebank accession: AF291702; forward primer: nucleotides (nts) 37--54 and a SacI restriction enzyme site; reverse primer: nts 1312--1330 and a SphI restriction enzyme site), the N ORF was amplified by reverse transcriptase polymerase chain reaction (RT-PCR) using Superscript One-step RT-PCR reagent (Invitrogen), digested using SacI and SphI restriction endonucleases (New England Biolabs, Ipswich, MA), and cloned into the identically digested pCAGGS vector. The ANDV N fragment was subcloned from the resulting plasmid into the pCDNA3.1(+) vector using EcoRI and XhoI restriction enzymes. The ANDV M segment ORF was amplified using M segment specific primers (Genebank accession: AF291703; forward primer: nts 46--63; reverse primer nts 3449--3469 and a KpnI restriction enzyme site), cloned into the pCR4-Blunt-TOPO vector (Invitrogen) according to the manufacturer\'s instructions. The M ORF fragment was excised using NotI and KpnI restriction endonucleases and this fragment was ligated to an EcoRI and KpnI digested pCAGGS vector after the EcoRI and NotI sites were blunt ended by a Klenow fill-in reaction. The sequences of both N and M ORF cDNAs were verified by DNA sequencing. The CD63-eGFP cDNA was kindly provided by David Sibley (Washington University, St. Louis, MO). The eGFP-Vps4A cDNA was kindly provided by Wes Sundquist (University of Utah, Salt Lake City, UT). The eGFP-Rab5a, eGFP-Rab7, eGFP-Rab11a, eGFP-Rab11S25N, and eGFP-Rab11Q70L, and Rab9 cDNAs were kindly provided by Phil Stahl (Washington University, St. Louis, MO). The VSV G cDNA was kindly provided by Garry Nolan (Stanford University, Palo Alto, CA). To construct the eGFP-Rab9 expression plasmid, Rab9 cDNA was amplified by PCR using canine Rab9 sequence specific primers (Genebank accession: X56386; forward primer: nts 1--28 and a XhoI restriction enzyme site; reverse primer: nts 585--606 and a KpnI restriction enzyme site) and cloned in frame with the eGFP ORF into the eGFP-C1 vector (Clontech, Mountain View, CA). The Rab8a cDNA was kindly provided by Ira Mellman (Yale University, New Haven CT). To construct N-terminal eGFP-fusions of Rab8a, canine Rab8 specific primers (Genebank accession: X56385; forward primer: nts 13--32 and containing a EcoRI restriction enzyme site; reverse primer: nts 613--633 and containing a XhoI restriction enzyme site) were used to amplify the Rab8 open reading frame by PCR before cloning into an EcoRI and SalI digested eGFP-C1 vector in frame with the eGFP ORF. The Rab8 dominant negative and constitutively active mutations were created using a four-primer PCR method. The Rab8T22N (GDP-bound) mutation was made using the following mutagenesis primers in addition to the outer primers above described to amplify the appropriate product from eGFP-Rab8wt: 5′ primer, 5′-GTGGGGAAGAATTGTGTCCTGTTC-3′; 3′ primer, 5′-GAACAGGACACAATTCTTCCCCAC-3′. The Rab8Q67L (GTP-bound mutation) was made using the following mutagenesis primers: 5′ primer, 5′-CACAGCTGGTCTAGAACGGTTT-3′; 3′ primer, 5′-AAACCGTTCTAGACCAGCTGTG-3′. The amplified fragments were cloned into the eGFP-C1 vector. All PCR amplified products and mutations were confirmed by sequencing.

DNA transfections {#section0070}
-----------------

Vero cells were seeded at 7.5 × 10^4^ cells/well on coverslips in 12-well dishes one day prior to transfection. Growth media was replaced with 0.5 ml OptiMEM media (Invitrogen) prior to transfection. LT1 transfection reagent (Mirus, Madison, WI) was diluted into 100 μL of OptiMEM, mixed and incubated for 15 min at room temperature. DNA was added to the LT1 solution, mixed and incubated for 15 min at room temperature. The cells were transfected with 1 μg of DNA at a ratio of 3 μL LT1 to 1 μg of DNA. For cotransfections, 0.5 μg of each plasmid was used. The transfection mixture was added to each well, followed by 0.5 ml of growth media at 4 h post transfection (hpt). At 18--24 hpt, cells were washed 1× in PBS and fixed for 10 min in 2% paraformaldehyde in PBS. For ANDV infected cell transfections, cells were infected at MOI = 0.5 and detached from the tissue culture dish at 72 h post infection (hpi) with 1× trypsin-EDTA. Cells were pelleted at 300 × g for 5 min, resuspended in growth media, and seeded on glass coverslips in a 12-well dish at a density of 1 × 10^5^ cells/well. At 24 h post seeding, cells were transfected as above described.

Immunofluorescence confocal microscopy {#section0075}
--------------------------------------

At the indicated time post infection or transfection cells were washed with PBS and fixed in 2% paraformaldehyde in PBS for 10 min at room temperature. After fixation, cells were washed extensively with PBS and permeabilized with PBS containing 0.2% TX-100 and 0.1% sodium citrate for 10 min at room temperature. The cells were incubated with PBS containing 3% normal goat or donkey serum and 0.5% BSA (blocking buffer) for 30 min at room temperature. Cells were incubated with primary antibodies followed by secondary antibodies. All antibodies were diluted in blocking buffer and incubation times were 1 h at room temperature. Nuclei were stained with TO-PRO-3 (Molecular Probes/Invitrogen) for 15 min at room temperature. All washes were performed with PBS. Coverslips were mounted with Molecular Probes Prolong Gold antifade (Molecular Probes/Invitrogen). Cells were visualized using a Zeiss LSM 510 Meta confocal microscope. Z-stacks were acquired at a 63× magnification, 1024 × 1024 pixel resolution, using 2× digital zoom (unless otherwise noted), 0.7 μm optical slice, and 0.3 μm slice overlap.

Volocity quantitation of confocal microscopy {#section0080}
--------------------------------------------

The amount of colocalization in the confocal z-stacks was quantitated using the Volocity (v3.0) imaging software (Improvision, Lexington, MA). Images were cropped to obtain the single cell to be quantitated. Classifiers were designed to measure three dimensional (3-D) regions according to signal intensity and region size. 3-D regions of intensity were measured using the following classifier parameters: intensity, \> 3 standard deviations above the mean (for eGFP signal), and \> 2 standard deviations above the mean for ANDV N; volume, \> 0.01 μm^3^; separation of touching objects; and noise reduction. Classifiers were applied to measure each channel to be colocalized. The measurement calculations for each channel were colocalized using the "colocalize sessions" option to overlay the two data sets and measure the regions of colocalization. All regions less than 10 voxels were removed and the total volume of colocalization was then normalized to the total volume measured for eGFP and expressed as percent colocalization.

Small interfering RNA transfection {#section0085}
----------------------------------

Small interfering RNA (siRNA) duplexes were purchased from Dharmacon (Lafayette, CO) and reconstituted at 20 μM stock concentrations according to the manufacturer\'s instructions. The siRNAs are designed against human Rab 8 and 11 isoforms and four siRNAs per transcript were used. Vero cells were infected in 3.5 cm^2^ dishes with ANDV at MOI = 0.5 and at 72 hpi, cells were detached from the tissue culture dish with 1× trypsin-EDTA and pelleted at 300 ×*g* for 5 min. Cells were resuspended in growth media and seeded into 24-well dishes at a density of 5 × 10^4^ cells/well. At 24 h post seeding (considered the 0 h timepoint), the cells were transfected with the siRNA duplexes using siQuest reagent (Mirus). For each well, 1.5 μL of siQuest reagent was diluted in 50 μL of OptiMEM media, mixed and incubated for 10 min at room temperature. The siRNAs were added to the siQuest solution at a final concentration of 50--100 nM, mixed and incubated for 30 min at room temperature. The infected-cell supernatant was harvested (0 h timepoint) and 250 μL of growth media was added to each well. The transfection mixture was added to the cells and transfections were incubated at 37 °C, 5% CO~2~. Supernatants and whole cell lysates were harvested at 48 hpt. Supernatants were titered by immune TCID~50~ and the fold reduction in titer was determined by dividing the titer at 0 hpt by the titer at 48 hpt (0 h TCID~50~ units/ml)/(48 h TCID~50~ units/ml). Virus titers were determined for duplicate siRNA transfections in four independent experiments.

SDS-PAGE and western blotting {#section0090}
-----------------------------

Cells were washed once in PBS and lysed in 1% sodium dodecyl sulfate (SDS). Lysates were run through a 22-gauge needle, sonicated for 15 min, and diluted in 2× SDS loading buffer ([@bib60]). Samples were boiled for 15 min and run on a 15% polyacrylamide mini gel (BioRad, Hercules, CA) at 150 volts (V) through the stacking gel followed by an additional 2 h at 100 V. Proteins were transferred to PVDF membrane (Immobilon-FL, Millipore, Billerica, MA) overnight at 22 V (Mini Transblot, BioRad). Membranes were blocked in 5% dry milk and incubated sequentially in primary and secondary antibodies for 1 h at room temperature. Washes were performed in PBS supplemented with 0.3% Tween20. HRP-conjugated secondary antibodies were detected using the ECL-Plus substrate (Amersham, Buckinghamshire, UK). Protein band intensities were quantitated by phosphorimager analysis (Fuji Film FLA3000, Tokyo, Japan).

Appendix A. Supplementary data {#app1}
==============================

Supplemental Fig. 1ANDV proteins colocalize with Rab8 and Rab11 when expressed from cDNA. Vero cells were transfected with cDNAs expressing either (A and B) eGFP-Rab8 or (D and E) eGFP-Rab11 in combination with (A and D) ANDV N (red, AlexaFluor 555) or (B and E) ANDV glycoproteins (M) (red, AlexaFluor 633). As a positive control for localization with these two Rabs, Vero cells were transfected with cDNAs expressing (C and F) VSV G (red, AlexaFluor 594) and (C) eGFP-Rab8 or (F) eGFP-Rab11. The cells were fixed at 18 hpt, immunostained for the viral proteins, and visualized by confocal microscopy. Images are flattened reconstructions of confocal z-stacks that were acquired at 63× optical magnification and 2× digital zoom.

This work was supported by Public Health Service grant R21 AI058353, The Eliasberg Foundation and The Marjorie Gilbert Foundation. We acknowledge the Molecular Microbiology Imaging Facility for technical support and all the members of the Pekosz laboratory for insightful comments and discussions.

Supplementary data associated with this article can be found, in the online version, at [doi:10.1016/j.virol.2008.09.021](10.1016/j.virol.2008.09.021).
